Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PUVA with or without maintenance in early-stage mycosis fungoides
2012-000212-28Phase 3Completed
- Sponsor
- Medical University of Graz
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of methoxsalen in mycosis fungoides (MF) (2 arms), sponsored by Medical University of Graz. Primary endpoint: Time to recurrence after complete remission. Started May 2012; status: completed.
02
Drugs
methoxsalen
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on 2012-000212-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000212-28.